Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release.
D-mannose
ciprofloxacin
microspheres
resveratrol
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
18 Oct 2022
18 Oct 2022
Historique:
received:
14
07
2022
revised:
03
10
2022
accepted:
16
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
This article describes the preparation, characterization, and performance evaluation of functional microspheres useful for the release of ciprofloxacin. The particles were obtained using D-mannose, a natural aldohexose sugar, and resveratrol, a powerful antioxidant. In particular, the above compounds were initially converted into D-mannose carboxylate and resveratrol methacrylate and, therefore, subjected to an esterification reaction. The resulting product was used for the preparation of the microspheres which were characterized by light scattering, FT-IR spectrophotometry and scanning electron microscopy (SEM). Subsequently, their degree of bloating was evaluated at pH 1.2 to simulate the pH of the stomach, at pH 6.8 and pH 7.4 to mimic the intestinal environment. The antibiotic ciprofloxacin was then loaded into the microspheres, with an encapsulation efficiency of 100%. The cumulative amount of drug released was 55% at pH 6.8 and 99% at pH 7.4. The tests conducted to evaluate the antibacterial activity demonstrated the ability of the microspheres obtained to inhibit the growth of
Identifiants
pubmed: 36295357
pii: ma15207293
doi: 10.3390/ma15207293
pmc: PMC9607382
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This research was funded by PON R&I 2014-2020-ARS01_00568-SI.F.I.PA.CRO.DE. -Sviluppo e industrializzazione farmaci innovativi per terapia molecolare personalizzata PA.CRO.DE.
ID : PON R&I 2014-2020-ARS01_00568-SI.F.I.PA.CRO.DE.
Références
Am J Obstet Gynecol. 2020 Aug;223(2):265.e1-265.e13
pubmed: 32497610
BMC Infect Dis. 2013 Jan 29;13:47
pubmed: 23356488
Exp Mol Pathol. 2008 Aug;85(1):11-9
pubmed: 18482721
J Agric Food Chem. 2004 Apr 21;52(8):2411-20
pubmed: 15080655
Int J Pharm. 2014 Jan 30;461(1-2):163-70
pubmed: 24296047
Carbohydr Polym. 2021 Feb 15;254:117421
pubmed: 33357902
Infect Immun. 1997 Oct;65(10):4199-206
pubmed: 9317027
J Cosmet Laser Ther. 2019;21(2):84-90
pubmed: 29737899
J Biomed Mater Res A. 2012 Feb;100(2):536-42
pubmed: 22162280
Nutr J. 2022 Mar 22;21(1):18
pubmed: 35313893
Colloids Surf B Biointerfaces. 2013 Sep 1;109:273-9
pubmed: 23668982
Sci Rep. 2019 Dec 20;9(1):19525
pubmed: 31862939
J Agric Food Chem. 2007 Nov 14;55(23):9489-95
pubmed: 17944531
Membranes (Basel). 2022 Jan 20;12(2):
pubmed: 35207043
Int J Pharm. 2006 Apr 7;312(1-2):151-7
pubmed: 16490328
Toxicol Appl Pharmacol. 2019 Mar 15;367:23-32
pubmed: 30711533
Molecules. 2020 Jan 13;25(2):
pubmed: 31941080
Colloids Surf B Biointerfaces. 2017 Mar 1;151:128-133
pubmed: 27988473
Colloids Surf B Biointerfaces. 2016 Sep 1;145:706-715
pubmed: 27289312
Compr Rev Food Sci Food Saf. 2016 Jul;15(4):773-785
pubmed: 33401842
Res Microbiol. 2020 Jul - Sep;171(5-6):165-173
pubmed: 32569709
J Mater Sci Mater Med. 2017 Nov 7;28(12):190
pubmed: 29116465
Biomed Rep. 2022 Jun 15;17(2):69
pubmed: 35815191
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5
pubmed: 7892228
Carbohydr Polym. 2019 Mar 15;208:431-440
pubmed: 30658821
J Pharm Pharmacol. 2016 Feb;68(2):275-81
pubmed: 26833423
Molecules. 2021 Mar 26;26(7):
pubmed: 33810514
Int J Pharm. 2011 Nov 28;420(2):290-6
pubmed: 21925255
Braz J Infect Dis. 2019 Jan - Feb;23(1):15-21
pubmed: 30796889
Oncotarget. 2017 Jul 7;8(40):67457-67472
pubmed: 28978045
Macromol Biosci. 2008 Jan 9;8(1):86-95
pubmed: 17787021
J Sci Food Agric. 2020 Mar 15;100(4):1392-1404
pubmed: 31756276
Biofouling. 2019 Aug;35(7):758-767
pubmed: 31505984
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229